Jazz Pharmaceuticals to Present at Investor Conferences

PALO ALTO, Calif., May 16 /PRNewswire-FirstCall/ -- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) announced today that Robert M. Myers, the company's President, will provide a corporate presentation at two upcoming investor conferences.

Mr. Myers will speak at the UBS Global Specialty and Generic Pharmaceuticals Conference in London at 9:30 a.m. BST (4:30 a.m. EDT) on Wednesday, May 28, 2008.

On Thursday, May 29, 2008 Mr. Myers will present at the FBR Capital Markets Spring Investor Conference in New York City at 8:15 a.m. EDT.

A live webcast of the presentations may be accessed by visiting the Investors section of the Jazz Pharmaceuticals website at http://www.JazzPharmaceuticals.com. A replay will be available on Jazz Pharmaceuticals' website for two weeks following each presentation.

About Jazz Pharmaceuticals, Inc.

Jazz Pharmaceuticals is a specialty pharmaceutical company focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry.

SOURCE Jazz Pharmaceuticals, Inc.

CONTACT: Matthew K. Fust, Executive Vice President and Chief Financial Officer of Jazz Pharmaceuticals, Inc.
+1-650-496-2800
investorinfo@jazzpharmaceuticals.com
Web site: http://www.jazzpharmaceuticals.com